Coffee & Compatibility cover art

All Episodes

Coffee & Compatibility — 73 episodes

#
Title
1

HLA in Cell Therapy: The Time Is Now!

2

Dr. Rose Payne: An HLA Trailblazer

3

This Is Not Yesterday’s Hematopoietic Stem Cell Transplant

4

Dr. Paul Terasaki: a story of Risk, Resilience, and Revolution

5

Media Coverage Sparks Organ Donor Registry Withdrawals

6

Who Says AMR Doesn’t Happen in Liver Transplant Patients?

7

The Impact of Drone Technology on the Future of Sample and Organ Allocation: Propelling Forward

8

The Present and Future of Transplant Modernization

9

The Power of Partnership: ASHI & ASCP Supporting the Clinical Laboratory Workforce

10

Innovation in Practice and Protection

11

The Evolving Science and Clinical Applications of HLA Structural Mismatch in Transplantation

12

The past, present and future, of the HLA database that HLA laboratories CANNOT survive without!

13

The Current Landscape of Organ Procurement Organization Regulatory Oversight

14

Innovation in Desensitization Therapy

15

The Normothermic Regional Perfusion (NRP) Revolution and What It Means for Organ Allocation

16

What should we be doing better? A transplant recipient’s perspective

17

CMS Updates, Guidance, and Clarifications

18

The Next 50 Years of ASHI

19

CMS, FDA and VALID Act...Oh, my! Where are we now?

20

The Vital Role of HLA Laboratories in Transfusion Support

21

Shifts in HLA Practice Drive Subsequent Evolution in the Interplay of HLA Data and Organ Allocation

22

Molecular testing in HLA and beyond

23

Current State of Donor-derived cell-free DNA testing for allograft rejection

24

International organ allocation practices: a spotlight on Portugal

25

Organ allocation in the U.S.

26

An ASHI Pioneer revisits wonderful ASHI Memories: Happy 50th ASHI!

27

Look how far we’ve come!

28

Accuracy in anti-HLA antibody identification assay analysis

29

New State Law aims to grow The Organ Donor Registry!

30

Coffee & Compatibility remembers the call to action from 2-time heart recipient, Amy Silverstein

31

ASHI’s Lab Professionals Recruitment Task Force

32

Live from the 2023 ASHI Annual Meeting

33

Growing your professional network!

34

Future Omic’s in Personalized Medicine

35

The Resident’s Starting Point

36

HLA Clinical Laboratories and BMT/HSCT Service

37

The ASHI Annual Meeting and why you should go!

38

Innovation in U.S. lung allocation

39

Using continuing education to advance your career with Phillip Fisher

40

Progress and Innovation in solid organ allocation equity

41

Next-generation sequencing (NGS) with Mr. John Sadowski

42

Algorithmic approaches to open allocation - Part 1

43

Carving your path through ASHI: A technologist’s perspective with Sharon Adams

44

Carving your path through ASHI: An interview with Dr. Nicholas Brown

45

Race, Ethnicity, Ancestry, and how they impact HLA Genotyping

46

Evolution of donor selection in Hematopoietic Stem Cell Transplantation (HSCT)

47

A different take on virtual crossmatch use in the U.S.

48

Algorithm development and discussion with PIRCHE VP Matthias Niemann

49

Live from the 2022 ASHI Annual Meeting

50

The Application and Design of Machine Learning in Healthcare

51

The road to best practices in anti-HLA antibody testing

52

Interview with Dr. Matthieu-P. Schapranow on the application of Artificial Intelligence

53

VALID Act: Call to Action

54

Concerns in Sickle Cell Disease with Dr. Yvette Miller

55

S.T.A.R. Workgroup series, episode 3: Non-HLA Antibody Testing

56

S.T.A.R. Workgroup series, episode 2: Alloimmunity

57

S.T.A.R. Workgroup Series, Episode 1: Histocompatibility Testing in Clinical Trials

58

Government relations in clinical laboratory science

59

Interview with Dr. Alexandre Loupy

60

Interview with Dr. Robert Montgomery

61

Wrapping up 2021

62

The field of bioinformatics

63

Live at the 2021 ASHI Annual Meeting

64

T-Cell Epitopes

65

Utilization of killer cell immunoglobulin–like receptor (KIR) testing in transplantation

66

Controversies in HLA

67

The Field of HLA: The Technologist Perspective

68

Exploring the upcoming 47th ASHI Hybrid Annual Meeting

69

ASHI celebrates Lab Week and Donate Life Month 2021

70

Interview with Editor in Chief of Human Immunology, Dr. Amy Hahn

71

COVID-19 Vaccine Information

72

Interview with ASHI President Dr. William Hildebrand

73

Trailer